Other studies have also suggested serum interleukin 6 [147] or STIR positive muscles’ chemokine (C-X-C motif) ligand 13 (CXCL13) expression [148] as potential FSHD biomarkers. The gene discussed is CXCL13; the disease is facioscapulohumeral muscular dystrophy.